CANF
Can-Fite BioPharma
CANF
CANF
9 hedge funds and large institutions have $179K invested in Can-Fite BioPharma in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$31.9K |
2 |
![]()
2
RhumbLine Advisers
Boston,
Massachusetts
|
$47.5K |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$1.22K |
Top Sellers
1 |
1
Morgan Stanley
New York
|
$87.5K |